Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vera Kemp

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Cytokine & Growth Factor Reviews|June 20, 2020
Developing oncolytic viruses for clinical use: A consortium approachVera Kemp, Martine L M Lamfers, Gabri van der Pluijm, et al.
Molecular Oncology|December 1, 2023
Preclinical evaluation of the gorilla-derived HAdV-B AdV-lumc007 oncolytic adenovirus 'GoraVir' for the treatment of pancreatic ductal adenocarcinomaSelas T F Bots, Tom J Harryvan, Christianne Groeneveldt, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 9, 2014
Granzyme K synergistically potentiates LPS-induced cytokine responses in human monocytesAnnette C Wensink, Vera Kemp, Job Fermie, et al.
Cancer Gene Therapy|November 24, 2018
Arming oncolytic reovirus with GM-CSF gene to enhance immunityVera Kemp, Diana J M van den Wollenberg, Marcel G M Camps, et al.
Cancer Gene Therapy|July 22, 2022
Gastrointestinal cancer-associated fibroblasts expressing Junctional Adhesion Molecule-A are amenable to infection by oncolytic reovirusTom J Harryvan, Matteo Golo, Nicole Dam, et al.
Virology|September 8, 2025
A new adenovirus isolated from a western lowland gorilla held in captivitySanne L Landman, Martijn J W E Rabelink, Selas T F Bots, et al.
International Journal of Molecular Sciences|March 13, 2025
Unusual Partners: γδ-TCR-Based T Cell Therapy in Combination with Oncolytic Virus Treatment for Diffuse Midline GliomasKonstantinos Vazaios, Patricia Hernández López, Tineke Aarts-Riemens, et al.
Human Gene Therapy|December 4, 2021
Nonhuman Primate Adenoviruses of the Human Adenovirus B Species Are Potent and Broadly Acting Oncolytic Vector CandidatesSelas T F Bots, Vera Kemp, Steve J Cramer, et al.
Molecular Therapy. Oncology|May 8, 2026
Boosting CAR T cell functionality with oncolytic viruses for the treatment of pediatric diffuse midline gliomasKonstantinos Vazaios, Antonio C Tallon-Cobos, Louisa P J van Oosterhout, et al.
Molecular Therapy. Oncology|May 2, 2024
The heterogeneous sensitivity of pediatric brain tumors to different oncolytic viruses is predicted by unique gene expression profilesKonstantinos Vazaios, Εftychia Stavrakaki, Lisette B Vogelezang, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Cytokine & Growth Factor Reviews|June 20, 2020
Developing oncolytic viruses for clinical use: A consortium approachVera Kemp, Martine L M Lamfers, Gabri van der Pluijm, et al.
Molecular Oncology|December 1, 2023
Preclinical evaluation of the gorilla-derived HAdV-B AdV-lumc007 oncolytic adenovirus 'GoraVir' for the treatment of pancreatic ductal adenocarcinomaSelas T F Bots, Tom J Harryvan, Christianne Groeneveldt, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 9, 2014
Granzyme K synergistically potentiates LPS-induced cytokine responses in human monocytesAnnette C Wensink, Vera Kemp, Job Fermie, et al.
Cancer Gene Therapy|November 24, 2018
Arming oncolytic reovirus with GM-CSF gene to enhance immunityVera Kemp, Diana J M van den Wollenberg, Marcel G M Camps, et al.
Cancer Gene Therapy|July 22, 2022
Gastrointestinal cancer-associated fibroblasts expressing Junctional Adhesion Molecule-A are amenable to infection by oncolytic reovirusTom J Harryvan, Matteo Golo, Nicole Dam, et al.
Virology|September 8, 2025
A new adenovirus isolated from a western lowland gorilla held in captivitySanne L Landman, Martijn J W E Rabelink, Selas T F Bots, et al.
International Journal of Molecular Sciences|March 13, 2025
Unusual Partners: γδ-TCR-Based T Cell Therapy in Combination with Oncolytic Virus Treatment for Diffuse Midline GliomasKonstantinos Vazaios, Patricia Hernández López, Tineke Aarts-Riemens, et al.
Human Gene Therapy|December 4, 2021
Nonhuman Primate Adenoviruses of the Human Adenovirus B Species Are Potent and Broadly Acting Oncolytic Vector CandidatesSelas T F Bots, Vera Kemp, Steve J Cramer, et al.
Molecular Therapy. Oncology|May 8, 2026
Boosting CAR T cell functionality with oncolytic viruses for the treatment of pediatric diffuse midline gliomasKonstantinos Vazaios, Antonio C Tallon-Cobos, Louisa P J van Oosterhout, et al.
Molecular Therapy. Oncology|May 2, 2024
The heterogeneous sensitivity of pediatric brain tumors to different oncolytic viruses is predicted by unique gene expression profilesKonstantinos Vazaios, Εftychia Stavrakaki, Lisette B Vogelezang, et al.
Pageof 3